Compound Detail
CHEMBL3582073
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3582073 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HXBVMAXHBKSTBQ-IUXPMGMMSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
401.8
MW (Da)
3.55
ALogP
5
HBA
2
HBD
96.6
PSA (Ų)
0.39
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 integrase CHEMBL3471 | IC50 | 6.89 | 5.79 | 130.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 integrase | IC50 | = | 130.0 | nM | 6.89 | Inhibition of HIV-1 integrase assessed as inhibition of strand transfer activity... | 25961960 |
| Human immunodeficiency virus type 1 integrase | IC50 | = | 20500.0 | nM | 4.69 | Inhibition of HIV-1 integrase assessed as inhibition of 3'-processing activity u... | 25961960 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25961960 | 10.1021/acs.jmedchem.5b00159 | Human immunodeficiency virus type 1 integrase | 2 |
| 25961960 | 10.1021/acs.jmedchem.5b00159 | Human immunodeficiency virus type 1 reverse transcriptase | 2 |
| 25961960 | 10.1021/acs.jmedchem.5b00159 | Human immunodeficiency virus 1 | 1 |
Data from ChEMBL 36 via Core Engine